Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases

<p>Diffuse liver disease can have a pronounced detrimental effect on the developing reproductive system. Hepatoprotection in gynecological practice is not so much in the choice of drugs that protect or restore the liver, as in the appointment of optimal safe therapy for this category of patien...

Full description

Bibliographic Details
Main Author: E. F. Chaykivska
Format: Article
Language:English
Published: Kazimierz Wielki University 2020-01-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/33178
_version_ 1818586525223354368
author E. F. Chaykivska
author_facet E. F. Chaykivska
author_sort E. F. Chaykivska
collection DOAJ
description <p>Diffuse liver disease can have a pronounced detrimental effect on the developing reproductive system. Hepatoprotection in gynecological practice is not so much in the choice of drugs that protect or restore the liver, as in the appointment of optimal safe therapy for this category of patients, especially in adolescence<strong>. The aim: </strong>to study the effectiveness of therapeutic and prophylactic drugs for disorders of the reproductive system in adolescent girls with diffuse liver disease. <strong>Material and methods.</strong> Under observation for the period 2010-2020 were 486 girls aged 12-17 years, of which 120 - with chronic viral hepatitis (CVH), 120 - with non-alcoholic fatty liver disease (NAFLD), 66 - with autoimmune hepatitis (AIH), 180 - conditionally somatically and gynecologically healthy girls with normal sexual development of the control group. All patients underwent general clinical, hepatological examination, determination of features of neuroendocrine status, sexual development. The author proposed a differentiated method of treatment and prevention measures to restore reproductive health in adolescents with chronic diffuse liver disease, which included the appointment of vitamin D, phytocompositions, vitamin-mineral complexes with myo-inositol, if necessary - hormonal hemostasis. <strong>Results. </strong>Against the background of improved neuroendocrine status in the examined girls there was a decrease in the number of cases of amenorrhea in the group with CVH from 5.00% to 0.00% (p&lt;0.01), in the group of NAFLD - from 27.50% to 3.33% (OR 11.00 [3.757-32.207]), in the AIH group - from 13.64% to 0.00% (p&lt;0.01); opsomenorrhea - from 24.17% to 2.50% (OR 12.43 [3,670-42,092]), from 67.50% to 7.50% (OR 25.62 [11.750-55.843]) and from 27. 27% to 6.06% (OR 5.81 [1.846-18.304]); oligomenorrhea - from 25.83% to 1.67% (OR 20.55 [4.791-88.152]), from 62.50% to 5.83% (OR 26.91 [11.52-62.83]) and from 27.27% to 4.55% (OR 7.88 [2.192-28.286]); juvenile uterine bleeding - from 18.33% to 1.67% (OR 13.25 [3.039-57.728]), from 10.00% to 0.00% (p&lt;0.01) and from 9.09% to 0.00% (p&lt;0.01); dysmenorrhea - from 38.33% to 12.50% (OR 4.20 [2.181-8.087]), from 14.17% to 5.00% (OR 3.14 [1.191-8.257]) and from 31.82 % to 13.64% (OR 2.96 [1.234-7.078]).<strong> Conclusions. </strong>The applied personalized treatment-and-prophylactic measures taking into account individual disorders of neuroendocrine status and menstrual health in adolescent girls with diffuse liver diseases are effective and allow to recommend this complex as a means of treatment and prevention of reproductive disorders.</p>
first_indexed 2024-12-16T08:54:21Z
format Article
id doaj.art-476a3814de3a467cb9647c38e8478688
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-12-16T08:54:21Z
publishDate 2020-01-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-476a3814de3a467cb9647c38e84786882022-12-21T22:37:19ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062020-01-0110133035310.12775/JEHS.2020.10.01.03626680Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseasesE. F. Chaykivska0Danylo Halytsky Lviv National Medical University<p>Diffuse liver disease can have a pronounced detrimental effect on the developing reproductive system. Hepatoprotection in gynecological practice is not so much in the choice of drugs that protect or restore the liver, as in the appointment of optimal safe therapy for this category of patients, especially in adolescence<strong>. The aim: </strong>to study the effectiveness of therapeutic and prophylactic drugs for disorders of the reproductive system in adolescent girls with diffuse liver disease. <strong>Material and methods.</strong> Under observation for the period 2010-2020 were 486 girls aged 12-17 years, of which 120 - with chronic viral hepatitis (CVH), 120 - with non-alcoholic fatty liver disease (NAFLD), 66 - with autoimmune hepatitis (AIH), 180 - conditionally somatically and gynecologically healthy girls with normal sexual development of the control group. All patients underwent general clinical, hepatological examination, determination of features of neuroendocrine status, sexual development. The author proposed a differentiated method of treatment and prevention measures to restore reproductive health in adolescents with chronic diffuse liver disease, which included the appointment of vitamin D, phytocompositions, vitamin-mineral complexes with myo-inositol, if necessary - hormonal hemostasis. <strong>Results. </strong>Against the background of improved neuroendocrine status in the examined girls there was a decrease in the number of cases of amenorrhea in the group with CVH from 5.00% to 0.00% (p&lt;0.01), in the group of NAFLD - from 27.50% to 3.33% (OR 11.00 [3.757-32.207]), in the AIH group - from 13.64% to 0.00% (p&lt;0.01); opsomenorrhea - from 24.17% to 2.50% (OR 12.43 [3,670-42,092]), from 67.50% to 7.50% (OR 25.62 [11.750-55.843]) and from 27. 27% to 6.06% (OR 5.81 [1.846-18.304]); oligomenorrhea - from 25.83% to 1.67% (OR 20.55 [4.791-88.152]), from 62.50% to 5.83% (OR 26.91 [11.52-62.83]) and from 27.27% to 4.55% (OR 7.88 [2.192-28.286]); juvenile uterine bleeding - from 18.33% to 1.67% (OR 13.25 [3.039-57.728]), from 10.00% to 0.00% (p&lt;0.01) and from 9.09% to 0.00% (p&lt;0.01); dysmenorrhea - from 38.33% to 12.50% (OR 4.20 [2.181-8.087]), from 14.17% to 5.00% (OR 3.14 [1.191-8.257]) and from 31.82 % to 13.64% (OR 2.96 [1.234-7.078]).<strong> Conclusions. </strong>The applied personalized treatment-and-prophylactic measures taking into account individual disorders of neuroendocrine status and menstrual health in adolescent girls with diffuse liver diseases are effective and allow to recommend this complex as a means of treatment and prevention of reproductive disorders.</p>https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/33178adolescentschronic diffuse liver diseasechronic viral hepatitisnonalcoholic fatty liver diseaseautoimmune hepatitisneuroendocrine statussexual developmentmenstrual healththerapeutic and prophylactic agentsvitamin dphytocompositionsvi
spellingShingle E. F. Chaykivska
Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
Journal of Education, Health and Sport
adolescents
chronic diffuse liver disease
chronic viral hepatitis
nonalcoholic fatty liver disease
autoimmune hepatitis
neuroendocrine status
sexual development
menstrual health
therapeutic and prophylactic agents
vitamin d
phytocompositions
vi
title Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
title_full Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
title_fullStr Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
title_full_unstemmed Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
title_short Personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
title_sort personified treatment and prevention of sexual developmental disorders in pubertal age girls with diffusive liver diseases
topic adolescents
chronic diffuse liver disease
chronic viral hepatitis
nonalcoholic fatty liver disease
autoimmune hepatitis
neuroendocrine status
sexual development
menstrual health
therapeutic and prophylactic agents
vitamin d
phytocompositions
vi
url https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/33178
work_keys_str_mv AT efchaykivska personifiedtreatmentandpreventionofsexualdevelopmentaldisordersinpubertalagegirlswithdiffusiveliverdiseases